Email In the second major drug merger in as many months, Monsanto Co. Monsanto's Searle division, which sells the popular arthritis treatment Celebrex, can be used to bolster next year's launch of Pharmacia's new antibiotic called Zyvox. The new company's pharmaceutical business will be headquartered in Peapack, N. The search for partners in the pharmaceutical industry is being driven by the need to finance research for blockbuster drugs, while facing pressure from political and consumer groups to keep prescription costs down.
New York Ticker Symbol: Our goal is to revitalize our company so that we enter the twenty-first century with growing competitive strength. We are developing the people, products, and programs that will lead us to that position. To do all this requires change. Our company is determined to become one that sees opportunities in change, that makes change an ally.
An international manufacturer of pharmaceuticals formed through the merger of the Pharmacia A. The company also develops and sells vaccines and pharmaceuticals for pets, livestock, and other food animals. The Origins of Upjohn It is not inaccurate to describe Upjohn's Victorian beginnings as marking the origin of modern pharmaceuticals in general.
William Upjohn revolutionized the drug industry when he patented a tedious process for the making of a "friable" pill capable of crumbling under the pressure of an individual's thumb. The image of Dr. Upjohn's thumb crushing a pill eventually became a trademark of the Upjohn Pill and Granule Co.
A talent for promoting its products ensured the company's steady growth through the turn of the century. By Upjohn could be seen at the Chicago World's Fair distributing souvenirs of its exhibit--an enormous bottle filled with colored pills.
In the company shortened its name to The Upjohn Company. Quinine pills and "Phenolax Wafers" the first candy laxative were two of the early and successful products made by Upjohn. From the very beginning, however, Upjohn not only emphasized the marketing of drugs, but also the research and development of new compounds.
In the company hired its first research scientist, a chemistry professor named Dr. The doctor proved to be a sound investment for Upjohn.
One of his developments, Citro-carbonate, an effervescent antacid, reached sales of one million dollars in Heyl was also responsible for patenting a digitalis tablet called Digitora, used in the treatment of heart disease and still sold by Upjohn into the s.
William Upjohn was largely responsible for the firm's early research orientation as well as its entrepreneurial spirit.
When William Upjohn died inthe job of running the company fell to his nephew, Dr. Upjohn, who served in that post for 12 years.
In Lawrence Upjohn retired and Donald S. Gilmore brought to the company valuable experience as a corporate executive from the business world, but even he was by no means an outsider. In fact, he was both the stepson and the son-in-law of William Upjohn. Parfet, president of the company beginning inalso married into the family.
The company had been so tightly held that until no one who was not a family member or employee of Upjohn was permitted to sit on its board of directors. Major Developments at Upjohn Through the s During the s and s, under the guidance of Lawrence Upjohn and later under Gilmore, the company expanded its research and manufacturing facilities and added 12 more research scientists.
This expansion paid off when Upjohn became the first to market an adreno-cortical hormone product in The actual impetus for the company's success occurred during World War II when Upjohn, like many other drug companies, developed a broad line of antibiotics, including penicillin and streptomycin.
Upjohn was fortunate enough to be selected by the armed forces to process human serum albumin and penicillin. By Upjohn was the sixth largest manufacturer of antibiotics. A substance made from beef bone gelatin, Gelfoam was a porous, sponge-like material which, when used during surgery, absorbed many times its volume in fluid and was itself absorbed by body tissues.
Gelfoam was also useful in the treatment of hemophiliacs, and when manufactured in a powder form that could be swallowed, Gelfoam was used to stop internal hemorrhaging that occurring in the digestive tract. Another successful product for the Upjohn Company during the postwar period was the injectable contraceptive Depo-Provera.
This drug provided protection against pregnancy for about 90 days. Though the drug would not gain FDA approval in the United States until the s, it was marketed in more than 80 foreign countries through subsidiaries located abroad.Pharmacia was a pharmaceutical and biotechnological company in Sweden that merged with the American pharmaceutical company Upjohn in Industry: Pharmaceutical.
Pursuant to the Distribution Agreement, Solutia assumed and agreed to indemnify Pharmacia (then known as Monsanto Company) for certain liabilities related to the Chemicals Business.
Dec. 19, Pharmacia (then known as Monsanto Company) entered into an agreement with Pharmacia & Upjohn, Inc. (PNU) relating to a merger . CHICAGO - Life sciences firm Monsanto Co.
and U.S.-Swedish drug group Pharmacia & Upjohn Inc. said on Sunday they agreed to merge, forming a company with a market capitalisation of more than $50 billion and an enviable collection of blockbuster drugs. Combining the operations of Monsanto and Pharmacia will save the new company $ million within three years.
Together, the companies have 60, employees. Pfizer and Pharmacia Merger Pfizer Inc and Pharmacia Corporation began operating as a unified company on April 16, , forging one of the world's fastest-growing and most valuable companies.
With a research and development budget of $ billion in , the new Pfizer is now the world's leading research-based pharmaceutical company. The Pharmacia-Upjohn merger brings together two powerful groups of roughly equal size.
Pharmacia is a niche drugs group specialising in drugs for growth hormones, cataract surgery and smoking.